Sánchez-Rico et al. J Travel Med. 2022


Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study.  Sánchez-Rico M, de la Muela P, Herrera-Morueco JJ, Geoffroy PA, Limosin F, Hoertel N. J Travel Med. 2022 Feb 5;. doi: 10.1093/jtm/taab195. [Epub ahead of print] PubMed PMID: 35137210. Download from HAL-INSERM


Melatonin is an hormone secreted from the pineal gland indicated in the treatment of insomnia and circadian sleep disturbances. In the needed search for an effective treatment for patients with COVID-19, this molecule has been previously proposed as a potential useful treatment against COVID-19 thanks to its antioxidant, immunomodulatory, anti-inflammatory and potential SARS-CoV-2 main protease inhibition activities. However, while a recent randomized clinical trial involving patients hospitalized with mild to moderate COVID-19 suggests that oral melatonin administration as an adjuvant therapy added to the standard of care may improve respiratory symptoms and time of patient discharge vs standard of care alone, another randomized trial found no substantial improvement in patients hospitalized for severe COVID-19. In this report, we used data from a multicenter retrospective study involving patients hospitalized for laboratory-confirmed COVID-19 in Greater Paris University hospitals, as detailed elsewhere, and sought to examine the association between melatonin use and mortality in this population. Observational studies examining the potential usefulness of existing treatments against COVID-19 can be crucial to help prioritize molecules in clinical trials.

This part of the website could either be in French or English, depending on the sources of the actualities.


 25 avril 2023
Hemorrhagic Stroke: Current Research regarding Etiological Diagnosis
 01 mars 2023 20 mars 2023
Semaine du Cerveau 25ème édition
 01 mars 2023 14 mars 2023
Conférence inaugurale de la Semaine du Cerveau: Neurosciences et Psychiatrie, un vertueux mariage
 24 février 2023 18 mars 2023
NeuroFrance 2023
 02 septembre 2022
The reciprocal interplay between nutrient sensing and secretory pathways defines cellular homeostasis
 01 juillet 2022
Cortical wiring by synapsespecific control of local protein synthesis
 20 juin 2022
Demars et al. Curr Biol. 2022
 03 juin 2022
Programming neural cells for disease modelling and therapy development
 06 mai 2022
Phenomenology and pathophysiology of antipsychotic-induced compulsive behaviour
 01 avril 2022
Medial Septum cholinergic inputs to CA2: a new role in social novelty discrimination
 04 mars 2022
Molecular Dissection of Selective Neuronal Vulnerability in Alzheimer's Disease
 23 février 2022
Sánchez-Rico et al. J Travel Med. 2022
 04 février 2022
Quantitative analysis and modelling of dendrite growth
 20 janvier 2022
Hoertel et al. Biol Psychiatry Glob Open Sci. 2022
 07 janvier 2022
Neurobiology of social and non social decision-making processes in mouse models
 21 décembre 2021 31 décembre 2021
Psychiatry and Neuroscience Seminar Series 2021
 03 décembre 2021
Deconstructing the role of dopamine signaling in defensive behaviors
 05 novembre 2021
Molecular mechanisms of synaptic development: insights from a human-specific gene
 01 octobre 2021
Implementing motor learning in stroke neurorehabilitation
 03 septembre 2021
Neurodegenerative diseases in the age of genetic engineering